Genetics and genetic testing raise key issues for insurance and employment. Governmental and public concern galvanised the British insurance industry into developing a code of practice. The history of the development of the code, issues of genetic discrimination, access to medical information, consent and the dangers of withholding information and the impact on the equity of pooled risk are explored. Proactive steps by the Association of British Insurers suggest that moral reflection not legislation is the way forward.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- A step forward, but still inadequate: Australian health professionals’ views on the genetics and life insurance moratorium
- Genetic discrimination in life insurance: empirical evidence from a cross sectional survey of genetic support groups in the United Kingdom
- Genetic discrimination in life insurance: a human rights issue
- Perceptions of genetic discrimination among people at risk for Huntington’s disease: a cross sectional survey
- The new genetics: Genetic testing and public policy
- 53 GENETIC DISCRIMINATION BY INSURERS AS A RESULT OF GENETIC RESEARCH AND TESTING: A COMPARISON OF NATIONAL POLICIES
- Genetics and public health—evolution, or revolution?
- Genetic counselling in ALS: facts, uncertainties and clinical suggestions
- Just a family medical history?
- Huntington’s disease